Selective inhibition of human glial inducible nitric oxide synthase by interferon-β: Implications for multiple sclerosis

Annals of Neurology

Volumn 43, Issue 3, 1998, Pages 384-387

  Hua, Liwei L ^a   Liu, Judy S H ^a   Brosnan, Celia F ^a   Lee, Sunhee C ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON;

ARTICLE; CELL CULTURE; DOSE RESPONSE; DRUG EFFECT; ENZYME INDUCTION; ENZYME INHIBITION; GENE EXPRESSION REGULATION; GLIA CELL; HUMAN; HUMAN CELL; IMMUNOTHERAPY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

ASTROCYTES; CELLS, CULTURED; ENZYME INDUCTION; HUMANS; INTERFERON-BETA; MULTIPLE SCLEROSIS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II;

EID: 0031952988     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410430317     Document Type: Article

References (22)

1. Raine CS. The Dale E. McFarlin memorial lecture: the immunology of the multiple sclerosis lesion. Ann Neurol 1994;36: S61-S72
2. Brosnan CF, Battistini L, Raine CS, et al. Reactive nitrogen intermediates in human neuropathology: an overview. Dev Neurosci 1994;16:152-161
3. Bo L, Dawson TM, Wesselingh S, et al. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol 1994;36:778-786
4. Merrill JE, Ignarro LJ, Sherman MP, et al. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 1993;151:2132-2141
5. Cross AH, Misko TP, Lin RF, et al. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J Clin Invest 1994;93:2684-2690
6. Bagasra O, Michaels FH, Zheng YM, et al. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc Natl Acad Sci USA 1995;92: 12041-12045
7. Tran EH, Hardin-Pouzet H, Verge G, Owens T. Astrocytes and microglia express inducible nitric oxide synthase in mice with experimental allergic encephalomyelitis. J Neuroimmunol 1997;74:121-129
8. Liu J, Zhao M-L, Brosnan CF, Lee SC. Expression of type II nitric oxide synthase in primary human astrocytes and microglia: role of IL-1β and IL-1 receptor antagonist. J Immunol 1996;157:3569-3576
9. Lee SC, Dickson DW, Liu W, Brosnan CF. Induction of nitric oxide synthase activity in human astrocytes by IL-1β and IFN-g. J Neuroimmunol 1993;46:19-24
10. Chao CC, Hu S, Sheng WS, et al. Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism. Glia 1996;16:276-284
11. Nathan C, Xie Q-W. Regulation of biosynthesis of nitric oxide. J Biol Chem 1994;269:13725-13728
12. Lee SC, Liu W, Brosnan CF, Dickson DW. Characterization of human fetal dissociated CNS cultures with an emphasis on microglia. Lab Invest 1992;67:465-475
13. Geller DA, Lowenstein CJ, Shapiro RA, et al. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci USA 1993;90:3491-3495
14. Weinstock-Guttman B, Ransohoff RM, Kinkel RP, Rudick RA. The interferons: biological effects, mechanisms of action, and use in multiple sclerosis. Ann Neurol 1994;37:7-15
15. Sen GC, Lengyel P. The interferon system: a bird's eye view of its biochemistry. J Biol Chem 1992;267:5017-5020
16. Ransohoff RM, Devajyothi C, Estes ML, et al. Interferon-beta specifically inhibits interferon-gamma-induced class II major histocompatibility complex gene transcription in a human astrocytoma cell line. J Neuroimmunol 1991;33:103-112
17. Satoh J, Paty DW, Kim SU. Differential effects of beta and gamma interferons on expression of major histocompatilibity complex antigens and intercellular adhesion molecule-1 in cultured fetal human astrocytes. Neurology 1995;45:367-373
18. Hall GL, Wing MG, Compston DAS, Scolding NJ. Beta-interferon regulates the immunomodulatory activity of neonatal rodent microglia. J Neuroimmunol 1997;72:11-19
19. Rudick RA, Ransohoff RM, Peppler R, et al. Interferon beta induces interleukin-10 expression: relevance to multiple sclerosis. Ann Neurol 1996;40:618-627
20. Brod SA, Marshall GD, Henninger EM, et al. Interferon-β1b treatment decreases tumor necrosis factor-α and increases interleukin-6 production in multiple sclerosis. Neurology 1996; 46:1633-1638
21. Stuve O, Dooley NP, Uhm JH, et al. Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9. Ann Neurol 1996;40:853-863
22. Stone LA, Frank JA, Albert PS, et al. The effect of interferon-beta on blood-brain barrier disruptions demonstrated by contrast-enhanced magnetic resonance imaging in relapsing-remitting multiple sclerosis. Ann Neurol 1995;37:611-617